Ochsner is committed to a clinically-integrated research program with the ultimate goal of improving the health and wellness of our patients and communities. As the largest academic medical center in Louisiana, we are training the next generation of healthcare professionals to be leaders who can meet evolving healthcare challenges.
Sequencing surveillance delivers critically important data both for local and state leadership to identify and understand which variants are circulating, where the variants are geographically and whether post-vaccine infections are the result of exposure to a variant strain of SARS-CoV-2. Individuals who have been vaccinated and test positive for COVID-19 may be contacted by the research team to gauge interest in participating in variant testing.
With a footprint spanning the state of Louisiana and into Mississippi, Ochsner Hospital for Children brings high quality pediatric care close to home, reducing barriers to healthcare – a key component of Ochsner’s 10-year vision to transform Louisiana into a healthier state by 2030.
Originally introduced in late July 2020 for adult volunteers ages 18-85 and November 2020 for adolescents ages 12-17, the Pfizer Phase 2/3 trial – with U.S. Food and Drug Administration (FDA) emergency approval – is now seeking children volunteers ages 5-11, with the goal of enrolling children as young as six months old in the near future.
At 75,000 square feet, it is double in size of the previous cancer center, increasing capacity to offer more high-quality cancer services and advanced clinical research than have ever been available on the Northshore.
Located at 8040 Goodwood Blvd., in Baton Rouge, Associates in Pediatrics & Adolescent Medicine has been committed to the attainment of optimal physical, mental, and social health and well-being for all newborns, infants, children, adolescents, and young adults for decades.